◆英語タイトル：Shield Therapeutics Plc (STX) - Financial and Strategic SWOT Analysis Review
Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non-salt, oral formulation of ferric iron-based pharmaceutical product used to treat iron deficiency anaemia (IDA). Shield Therapeutics provides PT20, an iron-based phosphate binder, developed to treat hyperphosphatemia related to dialysis-dependent or dialysis-independent chronic kidney disease (CKD). The company operates has operations in the UK, Germany and Switzerland. Shield Therapeutics is headquartered in Gateshead, the UK.
Shield Therapeutics Plc Key Recent Developments
Jan 22,2019: Shield Therapeutics names James Karis as non-executive Chairman
Sep 19,2018: Shield Therapeutics announces interim report for the six months ended 30 June 2018
Sep 13,2018: 13 Sep 2018 Shield reports completion of recruitment to AEGIS Head to Head Study. Shield Therapeutics plc, today announces completion of recruitment of the AEGIS–H2H Phase 3b study of oral Feraccru compared to Intravenous (IV) ferric carboxymaltose in sub
Jul 26,2018: Shield Therapeutics Announces Appointment of Non-Executive Director
This comprehensive SWOT profile of Shield Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shield Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Shield Therapeutics Plc – Key Information
Shield Therapeutics Plc – Overview
Shield Therapeutics Plc – Key Employees
Shield Therapeutics Plc – Key Employee Biographies
Shield Therapeutics Plc – Key Operational Heads
Shield Therapeutics Plc – Major Products and Services
Shield Therapeutics Plc – History
Shield Therapeutics Plc – Company Statement
Shield Therapeutics Plc – Locations And Subsidiaries
Shield Therapeutics Plc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Shield Therapeutics Plc – Business Description
Shield Therapeutics Plc – Corporate Strategy
Shield Therapeutics Plc – SWOT Analysis
SWOT Analysis – Overview
Shield Therapeutics Plc – Strengths
Shield Therapeutics Plc – Weaknesses
Shield Therapeutics Plc – Opportunities
Shield Therapeutics Plc – Threats
Shield Therapeutics Plc – Key Competitors
Section 3 – Company Financial Performance Charts
Shield Therapeutics Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Shield Therapeutics Plc, Key Information
Shield Therapeutics Plc, Key Ratios
Shield Therapeutics Plc, Share Data
Shield Therapeutics Plc, Major Products and Services
Shield Therapeutics Plc, History
Shield Therapeutics Plc, Key Employees
Shield Therapeutics Plc, Key Employee Biographies
Shield Therapeutics Plc, Key Operational Heads
Shield Therapeutics Plc, Other Locations
Shield Therapeutics Plc, Subsidiaries
Shield Therapeutics Plc, Key Manufacturing facilities
Shield Therapeutics Plc, Key Competitors
Shield Therapeutics Plc, SWOT Analysis
Shield Therapeutics Plc, Ratios based on current share price
Shield Therapeutics Plc, Annual Ratios
Shield Therapeutics Plc, Interim Ratios
Capital Market Ratios
List of Figures
Shield Therapeutics Plc, Performance Chart
Shield Therapeutics Plc, Ratio Charts
| ★海外企業調査レポート[Shield Therapeutics Plc (STX)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら